Medical Marijuana I(MJNA)
USD --+0.00%
Reward47Moderate
Risk56Medium-High
📊75%Data
Revenue down 47% YoY
MJNA
+0.0 · +0.00%
USD · PINK
Medical Marijuana I | Healthcare
Value Trap
Market Cap:1.99M
ℹ️
Reward Rating
47
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
56
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on MJNA to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Medical Marijuana I?

, an investment holding company, operates in the cannabinoid-based nutraceutical industry.

MJNA · Verdict

Moderate reward · elevated risk

MJNA stands out on volatility and valuation, but watch the balance sheet signal.

Based on 88% data coverage

MJNA · Verdict

What’s working & what to watch

Strengths 2

  • Volatility80/100

    Top decile vs peers

  • Valuation75/100

    Above average

Watchouts 3

  • Balance sheet25/100

    Current ratio 0.68

  • Growth35/100

    Rev -24.1% CAGR · earnings -48.8%

  • Cash flow45/100

    7% free-cash-flow margin

Model-based scoring. For information only — not financial advice.

What is Medical Marijuana I?

, an investment holding company, operates in the cannabinoid-based nutraceutical industry. It engages in creating international CBD pipeline; produces legal cannabis products; develops cannabis drug and medication; supports services for cannabis industry; and develops market for medical cannabis. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.99M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (47)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap1.99M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0004
52 Week Low0.0001
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding10B
No. of Employees91
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta0.549
CurrencyUSD